Cargando…
Type 2 diabetes is an independent predictor of lowered peak aerobic capacity in heart failure patients with non-reduced or reduced left ventricular ejection fraction
BACKGROUND: Although type 2 diabetes mellitus (T2DM) is one of the most frequent comorbidities in patients with chronic heart failure (CHF), the effects of T2DM on the exercise capacity of CHF patients are fully unknown. Here, we tested the hypothesis that the coexistence of T2DM lowers CHF patients...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502205/ https://www.ncbi.nlm.nih.gov/pubmed/32950064 http://dx.doi.org/10.1186/s12933-020-01114-4 |
_version_ | 1783584177673732096 |
---|---|
author | Abe, Takahiro Yokota, Takashi Fukushima, Arata Kakutani, Naoya Katayama, Takashi Shirakawa, Ryosuke Maekawa, Satoshi Nambu, Hideo Obata, Yoshikuni Yamanashi, Katsuma Nakano, Ippei Takada, Shingo Yokota, Isao Okita, Koichi Kinugawa, Shintaro Anzai, Toshihisa |
author_facet | Abe, Takahiro Yokota, Takashi Fukushima, Arata Kakutani, Naoya Katayama, Takashi Shirakawa, Ryosuke Maekawa, Satoshi Nambu, Hideo Obata, Yoshikuni Yamanashi, Katsuma Nakano, Ippei Takada, Shingo Yokota, Isao Okita, Koichi Kinugawa, Shintaro Anzai, Toshihisa |
author_sort | Abe, Takahiro |
collection | PubMed |
description | BACKGROUND: Although type 2 diabetes mellitus (T2DM) is one of the most frequent comorbidities in patients with chronic heart failure (CHF), the effects of T2DM on the exercise capacity of CHF patients are fully unknown. Here, we tested the hypothesis that the coexistence of T2DM lowers CHF patients’ peak aerobic capacity. METHODS: We retrospectively analyzed the cases of 275 Japanese CHF patients with non-reduced ejection fraction (left ventricular ejection fraction [LVEF] ≥ 40%) or reduced EF (LVEF < 40%) who underwent cardiopulmonary exercise testing. We divided them into diabetic and nondiabetic groups in each CHF cohort. RESULTS: The mean peak oxygen uptake (VO(2)) value was 16.87 mL/kg/min in the non-reduced LVEF cohort and 15.52 mL/kg/min in the reduced LVEF cohort. The peak VO(2) was lower in the diabetics versus the nondiabetics in the non-reduced LVEF cohort with the mean difference (95% confidence interval [95% CI]) of − 0.93 (− 1.82 to − 0.04) mL/kg/min and in the reduced LVEF cohort with the mean difference of − 1.05 (− 1.96 to − 0.15) mL/kg/min, after adjustment for age-squared, gender, anemia, renal function, LVEF, and log B-type natriuretic peptide (BNP). The adjusted VO(2) at anaerobic threshold (AT), a submaximal aerobic capacity, was also decreased in the diabetic patients with both non-reduced and reduced LVEFs. Intriguingly, the diabetic patients had a lower adjusted peak O(2) pulse than the nondiabetic patients in the reduced LVEF cohort, but not in the non-reduced LVEF cohort. A multivariate analysis showed that the presence of T2DM was an independent predictor of lowered peak VO(2) in CHF patients with non-reduced LVEF and those with reduced LVEF. CONCLUSIONS: T2DM was associated with lowered peak VO(2) in CHF patients with non-reduced or reduced LVEF. The presence of T2DM has a negative impact on CHF patients’ exercise capacity, and the degree of impact is partly dependent on their LV systolic function. |
format | Online Article Text |
id | pubmed-7502205 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-75022052020-09-22 Type 2 diabetes is an independent predictor of lowered peak aerobic capacity in heart failure patients with non-reduced or reduced left ventricular ejection fraction Abe, Takahiro Yokota, Takashi Fukushima, Arata Kakutani, Naoya Katayama, Takashi Shirakawa, Ryosuke Maekawa, Satoshi Nambu, Hideo Obata, Yoshikuni Yamanashi, Katsuma Nakano, Ippei Takada, Shingo Yokota, Isao Okita, Koichi Kinugawa, Shintaro Anzai, Toshihisa Cardiovasc Diabetol Original Investigation BACKGROUND: Although type 2 diabetes mellitus (T2DM) is one of the most frequent comorbidities in patients with chronic heart failure (CHF), the effects of T2DM on the exercise capacity of CHF patients are fully unknown. Here, we tested the hypothesis that the coexistence of T2DM lowers CHF patients’ peak aerobic capacity. METHODS: We retrospectively analyzed the cases of 275 Japanese CHF patients with non-reduced ejection fraction (left ventricular ejection fraction [LVEF] ≥ 40%) or reduced EF (LVEF < 40%) who underwent cardiopulmonary exercise testing. We divided them into diabetic and nondiabetic groups in each CHF cohort. RESULTS: The mean peak oxygen uptake (VO(2)) value was 16.87 mL/kg/min in the non-reduced LVEF cohort and 15.52 mL/kg/min in the reduced LVEF cohort. The peak VO(2) was lower in the diabetics versus the nondiabetics in the non-reduced LVEF cohort with the mean difference (95% confidence interval [95% CI]) of − 0.93 (− 1.82 to − 0.04) mL/kg/min and in the reduced LVEF cohort with the mean difference of − 1.05 (− 1.96 to − 0.15) mL/kg/min, after adjustment for age-squared, gender, anemia, renal function, LVEF, and log B-type natriuretic peptide (BNP). The adjusted VO(2) at anaerobic threshold (AT), a submaximal aerobic capacity, was also decreased in the diabetic patients with both non-reduced and reduced LVEFs. Intriguingly, the diabetic patients had a lower adjusted peak O(2) pulse than the nondiabetic patients in the reduced LVEF cohort, but not in the non-reduced LVEF cohort. A multivariate analysis showed that the presence of T2DM was an independent predictor of lowered peak VO(2) in CHF patients with non-reduced LVEF and those with reduced LVEF. CONCLUSIONS: T2DM was associated with lowered peak VO(2) in CHF patients with non-reduced or reduced LVEF. The presence of T2DM has a negative impact on CHF patients’ exercise capacity, and the degree of impact is partly dependent on their LV systolic function. BioMed Central 2020-09-19 /pmc/articles/PMC7502205/ /pubmed/32950064 http://dx.doi.org/10.1186/s12933-020-01114-4 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Original Investigation Abe, Takahiro Yokota, Takashi Fukushima, Arata Kakutani, Naoya Katayama, Takashi Shirakawa, Ryosuke Maekawa, Satoshi Nambu, Hideo Obata, Yoshikuni Yamanashi, Katsuma Nakano, Ippei Takada, Shingo Yokota, Isao Okita, Koichi Kinugawa, Shintaro Anzai, Toshihisa Type 2 diabetes is an independent predictor of lowered peak aerobic capacity in heart failure patients with non-reduced or reduced left ventricular ejection fraction |
title | Type 2 diabetes is an independent predictor of lowered peak aerobic capacity in heart failure patients with non-reduced or reduced left ventricular ejection fraction |
title_full | Type 2 diabetes is an independent predictor of lowered peak aerobic capacity in heart failure patients with non-reduced or reduced left ventricular ejection fraction |
title_fullStr | Type 2 diabetes is an independent predictor of lowered peak aerobic capacity in heart failure patients with non-reduced or reduced left ventricular ejection fraction |
title_full_unstemmed | Type 2 diabetes is an independent predictor of lowered peak aerobic capacity in heart failure patients with non-reduced or reduced left ventricular ejection fraction |
title_short | Type 2 diabetes is an independent predictor of lowered peak aerobic capacity in heart failure patients with non-reduced or reduced left ventricular ejection fraction |
title_sort | type 2 diabetes is an independent predictor of lowered peak aerobic capacity in heart failure patients with non-reduced or reduced left ventricular ejection fraction |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502205/ https://www.ncbi.nlm.nih.gov/pubmed/32950064 http://dx.doi.org/10.1186/s12933-020-01114-4 |
work_keys_str_mv | AT abetakahiro type2diabetesisanindependentpredictorofloweredpeakaerobiccapacityinheartfailurepatientswithnonreducedorreducedleftventricularejectionfraction AT yokotatakashi type2diabetesisanindependentpredictorofloweredpeakaerobiccapacityinheartfailurepatientswithnonreducedorreducedleftventricularejectionfraction AT fukushimaarata type2diabetesisanindependentpredictorofloweredpeakaerobiccapacityinheartfailurepatientswithnonreducedorreducedleftventricularejectionfraction AT kakutaninaoya type2diabetesisanindependentpredictorofloweredpeakaerobiccapacityinheartfailurepatientswithnonreducedorreducedleftventricularejectionfraction AT katayamatakashi type2diabetesisanindependentpredictorofloweredpeakaerobiccapacityinheartfailurepatientswithnonreducedorreducedleftventricularejectionfraction AT shirakawaryosuke type2diabetesisanindependentpredictorofloweredpeakaerobiccapacityinheartfailurepatientswithnonreducedorreducedleftventricularejectionfraction AT maekawasatoshi type2diabetesisanindependentpredictorofloweredpeakaerobiccapacityinheartfailurepatientswithnonreducedorreducedleftventricularejectionfraction AT nambuhideo type2diabetesisanindependentpredictorofloweredpeakaerobiccapacityinheartfailurepatientswithnonreducedorreducedleftventricularejectionfraction AT obatayoshikuni type2diabetesisanindependentpredictorofloweredpeakaerobiccapacityinheartfailurepatientswithnonreducedorreducedleftventricularejectionfraction AT yamanashikatsuma type2diabetesisanindependentpredictorofloweredpeakaerobiccapacityinheartfailurepatientswithnonreducedorreducedleftventricularejectionfraction AT nakanoippei type2diabetesisanindependentpredictorofloweredpeakaerobiccapacityinheartfailurepatientswithnonreducedorreducedleftventricularejectionfraction AT takadashingo type2diabetesisanindependentpredictorofloweredpeakaerobiccapacityinheartfailurepatientswithnonreducedorreducedleftventricularejectionfraction AT yokotaisao type2diabetesisanindependentpredictorofloweredpeakaerobiccapacityinheartfailurepatientswithnonreducedorreducedleftventricularejectionfraction AT okitakoichi type2diabetesisanindependentpredictorofloweredpeakaerobiccapacityinheartfailurepatientswithnonreducedorreducedleftventricularejectionfraction AT kinugawashintaro type2diabetesisanindependentpredictorofloweredpeakaerobiccapacityinheartfailurepatientswithnonreducedorreducedleftventricularejectionfraction AT anzaitoshihisa type2diabetesisanindependentpredictorofloweredpeakaerobiccapacityinheartfailurepatientswithnonreducedorreducedleftventricularejectionfraction |